类风湿关节炎与肺量计检查变化按吸烟状态分析:两项前瞻性纵向队列研究
分析英国生物银行与COPDGene两个前瞻性队列中233例类风湿关节炎(RA)患者和37735例非RA对照者的肺量计纵向变化,发现从不吸烟且无阻塞性通气模式的RA患者FEV1%下降更多(β=-0.49,p=0.04),而吸烟≥10包年的RA患者FEV1%下降反而更少(β=0.50,p=0.02),基线存在阻塞性模式者差异更明显(β=1.12,p=0.01)。
要点
- 从不吸烟且无阻塞性模式的RA患者FEV1%年下降较非RA对照更多(β=-0.49,p=0.04)。
- 吸烟≥10包年的RA患者FEV1%年下降较非RA对照更少(β=0.50,p=0.02)。
- 基线有阻塞性模式的吸烟RA患者FEV1%下降差异更明显(β=1.12,p=0.01)。
核心结论
- 吸烟的RA患者,尤其基线存在阻塞性肺量计模式者,FEV1%和FEV1/FVC年下降较非RA对照更少;从不吸烟的RA患者FEV1%年下降较非RA对照更多。
- 作者提出未来研究应探讨吸烟RA患者阻塞性肺疾病的潜在治疗和发病机制。
研究设计与样本
- 分析英国生物银行和COPDGene两个前瞻性队列的纵向数据,基线及5-7年后复查肺量计。
- RA依据自我报告和改善病情抗风湿药使用识别,非RA对照两者均无。
- 主要结局为FEV1%预计值和FVC%预计值的年变化,采用多因素线性回归,按基线吸烟状态和阻塞性模式(FEV1/FVC<0.7)分层。
主要发现
- 在完成基线和随访肺量计的参与者中,识别出233例RA患者和37735例非RA对照。
- 从不吸烟且无阻塞性模式的参与者中,RA与FEV1%下降更多显著相关(β=-0.49,p=0.04)。
- 吸烟≥10包年的参与者中,RA患者FEV1%下降较非RA对照显著更少(β=0.50,p=0.02)。
- 基线有阻塞性模式者中该差异更明显(β=1.12,p=0.01),FEV1/FVC下降结果相似。
- RA与非RA对照的FVC%年变化无差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare longitudinal changes in spirometric measures between patients with rheumatoid arthritis (RA) and non-RA comparators. METHODS: We analysed longitudinal data from two prospective cohorts: the UK Biobank and COPDGene. Spirometry was conducted at baseline and a second visit after 5-7 years. RA was identified based on self-report and disease-modifying antirheumatic drug use; non-RA comparators reported neither. The primary outcomes were annual changes in the per cent-predicted forced expiratory volume in 1 s (FEV1%) and per cent predicted forced vital capacity (FVC%). Statistical comparisons were performed using multivariable linear regression. The analysis was stratified based on baseline smoking status and the presence of obstructive pattern (FEV1/FVC <0.7). RESULTS: Among participants who underwent baseline and follow-up spirometry, we identified 233 patients with RA and 37 735 non-RA comparators. Among never-smoking participants without an obstructive pattern, RA was significantly associated with more FEV1% decline (β=-0.49, p=0.04). However, in ever smokers with ≥10 pack-years, those with RA exhibited significantly less FEV1% decline than non-RA comparators (β=0.50, p=0.02). This difference was more pronounced among those with an obstructive pattern at baseline (β=1.12, p=0.01). Results were similar for FEV1/FVC decline. No difference was observed in the annual FVC% change in RA versus non-RA. CONCLUSIONS: Smokers with RA, especially those with baseline obstructive spirometric patterns, experienced lower FEV1% and FEV1/FVC decline than non-RA comparators. Conversely, never smokers with RA had more FEV1% decline than non-RA comparators. Future studies should investigate potential treatments and the pathogenesis of obstructive lung diseases in smokers with RA.
引用
- Hayashi K, McDermott GC, Juge PA, et al. Rheumatoid arthritis and changes on spirometry by smoking status in two prospective longitudinal cohorts. RMD Open. 2024. PMID: 38886003. doi:10.1136/rmdopen-2024-004281
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。